NEPH logo

Nephros (NEPH) Shareholders Equity

Annual Shareholders Equity

$8.36 M
+$2.77 M+49.46%

December 31, 2023


Summary


Performance

NEPH Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNEPHbalance sheetmetrics:

Quarterly Shareholders Equity

$8.17 M
+$248.00 K+3.13%

September 1, 2024


Summary


Performance

NEPH Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNEPHbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

NEPH Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+49.5%-2.2%
3 y3 years-33.3%-2.2%
5 y5 years+120.1%-2.2%

NEPH Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-28.5%+49.5%-30.1%+46.2%
5 y5-year-33.3%+78.8%-34.7%+74.8%
alltimeall time-33.3%+204.5%-34.7%+185.6%

Nephros Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$8.17 M(+3.1%)
Jun 2024
-
$7.93 M(-3.1%)
Mar 2024
-
$8.18 M(-2.1%)
Dec 2023
$8.36 M(+49.5%)
$8.36 M(-3.1%)
Sep 2023
-
$8.62 M(-0.4%)
Jun 2023
-
$8.65 M(-2.7%)
Mar 2023
-
$8.89 M(+59.0%)
Dec 2022
$5.59 M(-52.2%)
$5.59 M(-11.3%)
Sep 2022
-
$6.30 M(-31.7%)
Jun 2022
-
$9.22 M(-9.2%)
Mar 2022
-
$10.16 M(-13.1%)
Dec 2021
$11.70 M(-6.6%)
$11.70 M(-4.7%)
Sep 2021
-
$12.28 M(+2.8%)
Jun 2021
-
$11.94 M(-4.4%)
Mar 2021
-
$12.48 M(-0.3%)
Dec 2020
$12.52 M(+167.9%)
$12.52 M(+49.3%)
Sep 2020
-
$8.39 M(-9.1%)
Jun 2020
-
$9.23 M(-12.9%)
Mar 2020
-
$10.60 M(+126.7%)
Dec 2019
$4.67 M(+23.1%)
$4.67 M(+25.9%)
Sep 2019
-
$3.71 M(-2.4%)
Jun 2019
-
$3.80 M(+46.0%)
Mar 2019
-
$2.60 M(-31.4%)
Dec 2018
$3.80 M(+94.8%)
$3.80 M(-6.6%)
Sep 2018
-
$4.07 M(-9.6%)
Jun 2018
-
$4.50 M(+137.0%)
Mar 2018
-
$1.90 M(-2.7%)
Dec 2017
$1.95 M(+192.4%)
$1.95 M(+635.8%)
Sep 2017
-
$265.00 K(-66.2%)
Jun 2017
-
$783.00 K(-43.0%)
Mar 2017
-
$1.37 M(+106.0%)
Dec 2016
$667.00 K(-75.0%)
$667.00 K(-45.2%)
Sep 2016
-
$1.22 M(-27.3%)
Jun 2016
-
$1.67 M(-16.1%)
Mar 2016
-
$1.99 M(-25.2%)
Dec 2015
$2.66 M(-146.9%)
$2.66 M(-4.6%)
Sep 2015
-
$2.79 M(-147.1%)
Jun 2015
-
-$5.93 M(+9.6%)
Mar 2015
-
-$5.41 M(-4.8%)
Dec 2014
-$5.68 M
-$5.68 M(+1371.8%)
Sep 2014
-
-$386.00 K(-278.7%)
Jun 2014
-
$216.00 K(-71.8%)
DateAnnualQuarterly
Mar 2014
-
$766.00 K(-120.6%)
Dec 2013
-$3.72 M(+525.0%)
-$3.72 M(-964.9%)
Sep 2013
-
$430.00 K(-48.9%)
Jun 2013
-
$841.00 K(-149.6%)
Mar 2013
-
-$1.70 M(+185.0%)
Dec 2012
-$595.00 K(-141.9%)
-$595.00 K(-284.2%)
Sep 2012
-
$323.00 K(-64.0%)
Jun 2012
-
$897.00 K(-13.2%)
Mar 2012
-
$1.03 M(-27.2%)
Dec 2011
$1.42 M(+952.6%)
$1.42 M(-23.3%)
Sep 2011
-
$1.85 M(-16.8%)
Jun 2011
-
$2.23 M(-19.9%)
Mar 2011
-
$2.78 M(+1960.7%)
Dec 2010
$135.00 K(-93.1%)
$135.00 K(-83.1%)
Sep 2010
-
$798.00 K(-25.8%)
Jun 2010
-
$1.07 M(-23.9%)
Mar 2010
-
$1.41 M(-27.9%)
Dec 2009
$1.96 M(-22.7%)
$1.96 M(-18.8%)
Sep 2009
-
$2.41 M(+70.8%)
Jun 2009
-
$1.41 M(-19.8%)
Mar 2009
-
$1.76 M(-30.5%)
Dec 2008
$2.53 M(-71.1%)
$2.53 M(-25.6%)
Sep 2008
-
$3.41 M(-29.2%)
Jun 2008
-
$4.81 M(-33.4%)
Mar 2008
-
$7.23 M(-17.4%)
Dec 2007
$8.76 M(-517.7%)
$8.76 M(-255.2%)
Sep 2007
-
-$5.64 M(+13.4%)
Jun 2007
-
-$4.97 M(+43.5%)
Mar 2007
-
-$3.47 M(+65.4%)
Dec 2006
-$2.10 M(-139.0%)
-$2.10 M(-2463.0%)
Sep 2006
-
$88.70 K(-95.3%)
Jun 2006
-
$1.90 M(-49.4%)
Mar 2006
-
$3.76 M(-30.0%)
Dec 2005
$5.38 M(-44.3%)
$5.38 M(-19.4%)
Sep 2005
-
$6.68 M(-19.9%)
Jun 2005
-
$8.34 M(-19.4%)
Mar 2005
-
$10.34 M(+7.2%)
Dec 2004
$9.65 M(-279.3%)
$9.65 M(-15.4%)
Sep 2004
-
$11.41 M(-219.4%)
Jun 2004
-
-$9.55 M
Dec 2003
-$5.38 M(-32.7%)
-
Dec 2002
-$8.00 M
-

FAQ

  • What is Nephros annual stockholders equity?
  • What is the all time high annual shareholders equity for Nephros?
  • What is Nephros annual shareholders equity year-on-year change?
  • What is Nephros quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Nephros?
  • What is Nephros quarterly shareholders equity year-on-year change?

What is Nephros annual stockholders equity?

The current annual shareholders equity of NEPH is $8.36 M

What is the all time high annual shareholders equity for Nephros?

Nephros all-time high annual stockholders equity is $12.52 M

What is Nephros annual shareholders equity year-on-year change?

Over the past year, NEPH annual stockholders equity has changed by +$2.77 M (+49.46%)

What is Nephros quarterly stockholders equity?

The current quarterly shareholders equity of NEPH is $8.17 M

What is the all time high quarterly shareholders equity for Nephros?

Nephros all-time high quarterly stockholders equity is $12.52 M

What is Nephros quarterly shareholders equity year-on-year change?

Over the past year, NEPH quarterly stockholders equity has changed by -$184.00 K (-2.20%)